• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

RNA binding protein RBM5 modulates chemotherapy resistance

Research Project

Project/Area Number 22590677
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionHokkaido University

Principal Investigator

KOBAYASHI Takahiko  北海道大学, 大学院・医学研究科, 客員研究員 (80333607)

Project Period (FY) 2010 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2012: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Keywords薬剤耐性 / 抗癌剤 / RBM5 / 抗癌剤耐性
Research Abstract

Prognostic value of RBM5 in gastric cancer was evaluated and compared with other histopathologic parameters. RBM5 protein expression was determined by immunohistochemistryin 106 gastric carcinomas. Reduced expression of RBM5 was observed in 29 cases (27.4%), and it was correlated with tumor size, depth, histological classification, and advanced stage. Furthermore, it was significantly associated with unfavourable prognosis. Furthermore, knockdown of endogenous RBM5 led to decreased p53 and p21 protein expression levels in gastric cancer cells, and increased drug resistance against 5-fluorouracil. Taken together, these results suggest that decreased function of RBM5is associated with malignant transformation and resistance to cancer chemotherapies.

Report

(4 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Annual Research Report
  • 2010 Annual Research Report
  • Research Products

    (3 results)

All 2011

All Journal Article (3 results) (of which Peer Reviewed: 3 results)

  • [Journal Article] p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5.2011

    • Author(s)
      Kobayashi T, Ishida J, Musashi M, Ota S, Y oshida T, Shimizu Y, Chuma M, Kawakami H, Asaka M, Tanaka J, Imamura M, Kobayas hi M, Itoh H, Edamatsu H, Sutherland LC, B rachmann RK.
    • Journal Title

      Int J Cancer

      Volume: 128(2) Issue: 2 Pages: 304-318

    • DOI

      10.1002/ijc.25345

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin2011

    • Author(s)
      Asanuma S., et.al.
    • Journal Title

      Ann Hematol

      Volume: 90 Issue: 6 Pages: 617-624

    • DOI

      10.1007/s00277-010-1121-z

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5.2011

    • Author(s)
      Kobayashi T
    • Journal Title

      Int J Cancer

      Volume: 128 Pages: 304-318

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed

URL: 

Published: 2010-08-23   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi